Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark...

FDA Recall #D-0462-2025 — Class III — May 19, 2025

Recall #D-0462-2025 Date: May 19, 2025 Classification: Class III Status: Ongoing

Product Description

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

Recalling Firm

Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

6,759 Con - 90 bottle pack

Distribution

Nationwide USA and PR

Code Information

Lot #: 17240195, Exp 01/31/2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated